Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research Units
Research output
Search by expertise, name or affiliation
Managing regulatory T cells to improve cancer immunotherapy
Tyler J Curiel
Department of Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Managing regulatory T cells to improve cancer immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Regulatory T Cell
100%
Immune Disorder
16%
Effector Cell
16%
Tumor Immunity
16%
Cancer Immunotherapy
16%
Differentiation
16%
Regulatory Cell
16%
CD4
8%
Hemocyte
8%
Solid
8%
CD25
8%
Immunocompetent Cell
8%
Survival
8%
Regulatory Mechanism
8%
Peripheral Circulation
8%
Medicine and Dentistry
Malignant Neoplasm
58%
Neoplasm
16%
Tumor Immunity
16%
Cancer Immunotherapy
16%
Differentiation
16%
Patient
16%
Regulatory T Cell
16%
Solid Malignant Neoplasm
8%
Treatment Response
8%
Depletion
8%
Histology
8%
Combination Therapy
8%
Blood Cell
8%
Therapeutic Management
8%
Peripheral Circulation
8%
Immunocompetent Cell
8%
Survival
8%
Therapeutic Procedure
8%
Regulatory Mechanism
8%
Mechanism of Action
8%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
25%
Regulatory T Cell
16%
Tumor Immunity
16%
Cancer Immunotherapy
16%
CD4
8%
Solid
8%
CD25
8%
Peripheral Circulation
8%
Immunocompetent Cell
8%
Survival
8%
Regulatory Mechanism
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
58%
Neoplasm
16%
Solid Malignant Neoplasm
8%
Survival
8%
Neuroscience
Cancer Immunotherapy
16%
Histology
8%
CD4
8%